Treatment of Neuropathy

Details for Australian Patent Application No. 2002301821 (hide)

Owner Pfizer Inc.

Inventors Koppiker, Nandan Parmandand; Forster, Eliot Richard

Agent Spruson & Ferguson

Pub. Number AU-B-2002301821

Parent 66650

Filing date 5 November 2002

Wipo publication date 6 March 2003

Acceptance publication date 20 July 2006

International Classifications

A61K 31/522 (2006.01)

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

Event Publications

28 November 2002 Complete Application Filed

6 March 2003 Application Open to Public Inspection

  Published as AU-B-2002301821

20 July 2006 Application Accepted

  Published as AU-B-2002301821

16 November 2006 Standard Patent Sealed

13 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002301822-Beam for Drywall Ceiling

2002301820-AlMgMn Alloy Product for Welded Construction with Improved Corrosion Resistance